Estrella Immunopharma, Inc. - 10-Q Filing
Estrella Immunopharma reports Q3 2026 results with ongoing going concern disclosures and significant R&D/G&A expense activity.
Tickers: $ESLA
Estrella Immunopharma reports Q3 2026 results with ongoing going concern disclosures and significant R&D/G&A expense activity.
Tickers: $ESLA